Basiliximab


Basiliximab

drugbox-mab


source = Chimeric/Human
target = CD25
width = 220px
CAS_number = 152923-56-3
ATC_prefix = L04
ATC_suffix = AA09
ATC_supplemental =
PubChem =
DrugBank = BTD00073
C=6378|H=9844|N=1698|O=1997|S=48
molecular_weight = 143801.3 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life = 7.2 days
pregnancy_US = B
pregnancy_category =
legal_status =
routes_of_administration =

Basiliximab ("Simulect") is a chimeric mouse-human monoclonal antibody to the IL-2Rα receptor of T cells. [IL-2Rα receptor is also known as the CD25 T-cell antigen] It is used to prevent rejection in organ transplantation, especially in kidney transplants. It is a Novartis Pharmaceuticals product [ [http://www.pharma.us.novartis.com/products/name/simulect.jsp Novartis product page for Simulect (basiliximab for injection) ] . Retrieved 2005-03-09.] and was approved by the Food and Drug Administration (FDA) in 1998. [Waldman, Thomas A. (2003). [http://www.nature.com/cgi-taf/DynaPage.taf?file=/nm/journal/v9/n3/full/nm0303-269.html&filetype=pdf Immunotherapy: past, present and future] . "Nature Medicine" 9, 269-277.]

It is given in two doses, the first within 2 hours of the start of the transplant operation and the second 4 days after the transplant. These saturate the receptors and prevent T cells from replication and also from activating the B cells, which are responsible for the production of antibodies, which would bind to the transplanted organ and stimulate an immune response against the transplant.

Like the similar drug daclizumab, basiliximab reduces the incidence and severity of acute rejection in kidney transplantation without increasing the incidence of opportunistic infections. In the United Kingdom, the National Institute for Health and Clinical Excellence has recommended its use be considered for all kidney transplant recipients.

References & Notes


Wikimedia Foundation. 2010.

Look at other dictionaries:

  • Basiliximab — Masse/Länge Primärstruktur 143,8 kDa …   Deutsch Wikipedia

  • Basiliximab — Saltar a navegación, búsqueda Basiliximab …   Wikipedia Español

  • basiliximab — noun A monoclonal antibody used to prevent rejection in organ transplantation, especially in kidney transplants …   Wiktionary

  • basiliximab — bas·i·lix·i·mab (bas″ĭ liksґĭ mab) an interleukin 2 receptor antagonist produced by recombinant technology as a chimeric mouse/human monoclonal antibody; it is used as an immunosuppressant for prophylaxis of acute organ rejection… …   Medical dictionary

  • Monoclonal antibodies — A general representation of the methods used to produce monoclonal antibodies. Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are the same because they are made by identical immune cells that are all clones of a unique… …   Wikipedia

  • Daclizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target CD25 Clinical data Trade names Zenapax AHFS/Drugs.com …   Wikipedia

  • Omalizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target IgE Fc region …   Wikipedia

  • Natalizumab — ? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target alpha 4 integrin Clinical data Trade names Tysabri AHFS/ …   Wikipedia

  • Monoclonal antibody therapy — Each antibody binds only one specific antigen. Monoclonal antibody therapy is the use of monoclonal antibodies (or mAb) to specifically bind to target cells or proteins. This may then stimulate the patient s immune system to attack those cells.… …   Wikipedia

  • Metelimumab — ? Monoclonal antibody Type Whole antibody Source Human Target TGF beta 1 Clinical data Pregnancy cat.  ? Legal status …   Wikipedia


Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”

We are using cookies for the best presentation of our site. Continuing to use this site, you agree with this.